WEAVER GREGORY L 4
4 · Altimmune, Inc. · Filed Apr 1, 2026
Research Summary
AI-generated summary of this filing
Altimmune (ALT) CFO Gregory L. Weaver Buys 10,000 Shares
What Happened Gregory L. Weaver, CFO of Altimmune, Inc. (ALT), purchased 10,000 shares on April 1, 2026 via open-market transactions (transaction code P). The weighted average price reported is $3.15 per share, for a total acquisition value of $31,499. This was a purchase (a potential bullish signal rather than a sale).
Key Details
- Transaction date: 2026-04-01
- Transaction type: Open-market purchase (Code P)
- Shares acquired: 10,000
- Reported price: Weighted average $3.15 per share (total $31,499)
- Price range (per footnote): purchases occurred at prices from $3.1450 to $3.1499; the reporting person will provide a breakdown on request (Footnote F1)
- Shares owned after transaction: Not disclosed in the provided filing
- Filing timeliness: Report filed on 2026-04-01 (same day as the Period of Report); no late filing indicated
Context This was a straightforward open-market buy by a company executive (not an option exercise or gift). The filing includes a footnote clarifying the reported price is a weighted average across multiple trades and offers to supply the transaction-by-transaction breakdown if requested. The purchase size (~$31.5k) is modest in dollar terms; retail investors may view insider buys as informative but should combine this information with other research before drawing conclusions.
Insider Transaction Report
- Purchase
Common Stock, par value $0.0001
[F1]2026-04-01$3.15/sh+10,000$31,499→ 38,078 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.1450 to $3.1499, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.